Bristol Myers Squibb Co. (BMY)
58.80
+0.46
(+0.79%)
USD |
NYSE |
Nov 20, 16:00
58.68
-0.12
(-0.20%)
After-Hours: 20:00
Bristol Myers Squibb Total Return Level : 224.76 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 224.76 |
| November 19, 2026 | 223.00 |
| November 18, 2026 | 227.66 |
| November 17, 2026 | 234.50 |
| November 16, 2026 | 240.54 |
| November 13, 2026 | 242.45 |
| November 12, 2026 | 238.21 |
| November 11, 2026 | 240.47 |
| November 10, 2026 | 240.05 |
| November 09, 2026 | 237.52 |
| November 06, 2026 | 237.52 |
| November 05, 2026 | 241.31 |
| November 04, 2026 | 245.36 |
| November 03, 2026 | 235.88 |
| November 02, 2026 | 240.89 |
| October 30, 2026 | 238.82 |
| October 29, 2026 | 234.66 |
| October 28, 2026 | 231.52 |
| October 27, 2026 | 235.27 |
| October 26, 2026 | 235.50 |
| October 23, 2026 | 235.00 |
| October 22, 2026 | 240.81 |
| October 21, 2026 | 233.62 |
| October 20, 2026 | 235.77 |
| October 19, 2026 | 224.87 |
| Date | Value |
|---|---|
| October 16, 2026 | 228.39 |
| October 15, 2026 | 231.52 |
| October 14, 2026 | 226.59 |
| October 13, 2026 | 216.62 |
| October 12, 2026 | 220.09 |
| October 09, 2026 | 225.98 |
| October 08, 2026 | 227.74 |
| October 07, 2026 | 228.20 |
| October 06, 2026 | 227.78 |
| October 05, 2026 | 224.80 |
| October 02, 2026 | 233.74 |
| October 01, 2026 | 232.53 |
| September 30, 2026 | 236.09 |
| September 29, 2026 | 237.83 |
| September 28, 2026 | 241.68 |
| September 25, 2026 | 237.83 |
| September 24, 2026 | 232.68 |
| September 23, 2026 | 231.36 |
| September 22, 2026 | 235.52 |
| September 21, 2026 | 236.92 |
| September 18, 2026 | 238.58 |
| September 17, 2026 | 237.75 |
| September 16, 2026 | 240.63 |
| September 15, 2026 | 241.12 |
| September 14, 2026 | 242.52 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Johnson & Johnson | 645.40 |
| Eli Lilly & Co. | 3563.61 |
| Merck & Co., Inc. | 413.52 |
| Pfizer Inc. | 92.99 |
| AstraZeneca PLC | 440.08 |